Dermatitis Stocks List

Recent Signals

Date Stock Signal Type
2021-05-06 ARQT Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-05-06 ARQT Upper Bollinger Band Walk Strength
2021-05-06 ATNX 20 DMA Support Bullish
2021-05-06 ATNX 50 DMA Resistance Bearish
2021-05-06 ATNX Slingshot Bullish Bullish Swing Setup
2021-05-06 BHC Lower Bollinger Band Walk Weakness
2021-05-06 BHC Doji - Bullish? Reversal
2021-05-06 BHC Stochastic Reached Oversold Weakness
2021-05-06 BHC Calm After Storm Range Contraction
2021-05-06 CCXI Narrow Range Bar Range Contraction
2021-05-06 CCXI NR7 Range Contraction
2021-05-06 CCXI Calm After Storm Range Contraction
2021-05-06 CCXI Boomer Sell Setup Bearish Swing Setup
2021-05-06 CCXI Lower Bollinger Band Walk Weakness
2021-05-06 EDSA Upper Bollinger Band Walk Strength
2021-05-06 EDSA Calm After Storm Range Contraction
2021-05-06 FBRX Fell Below 200 DMA Bearish
2021-05-06 FBRX Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-05-06 FBRX 50 DMA Support Bullish
2021-05-06 HOTH Stochastic Reached Oversold Weakness
2021-05-06 KIN Expansion Pivot Sell Setup Bearish Swing Setup
2021-05-06 KIN 200 DMA Support Bullish
2021-05-06 KYMR 20 DMA Support Bullish
2021-05-06 REGN Wide Range Bar Range Expansion
2021-05-06 REGN Pocket Pivot Bullish Swing Setup
2021-05-06 REGN 180 Bullish Setup Bullish Swing Setup
2021-05-06 REGN Crossed Above 20 DMA Bullish
2021-05-06 TLGT Stochastic Reached Oversold Weakness
2021-05-06 TLGT Bollinger Band Squeeze Range Contraction
2021-05-06 VYNE MACD Bearish Signal Line Cross Bearish
2021-05-06 VYNE New 52 Week Low Weakness
2021-05-06 VYNE New 52 Week Closing Low Bearish
2021-05-06 VYNE Volume Surge Other
2021-05-06 VYNE Expansion Breakdown Bearish Swing Setup

Recent News for Dermatitis Stocks

Date Stock Title
May 6 CCXI The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FGEN, CS and CCXI
May 6 CCXI CHEMOCENTRYX SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ChemoCentryx, Inc. - CCXI
May 6 CCXI Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of ChemoCentryx, Inc. (CCXI) on Behalf of Investors
May 6 CCXI SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
May 6 CCXI The Law Offices of Frank R. Cruz Announces Investigation of ChemoCentryx, Inc. (CCXI) on Behalf of Investors
May 6 CCXI FDA panel split 9-9 on efficacy for Chemocentryx's vasculitis candidate avacopan
May 6 CCXI CLASS ACTION UPDATE for EBS, VRUS and CCXI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
May 6 REGN US STOCKS-Dow ends at record high after upbeat jobless claims report
May 6 REGN Regeneron Pharmaceuticals, Inc. (REGN) CEO Leonard Schleifer on Q1 2021 Results - Earnings Call Transcript
May 6 REGN US STOCKS-Dow closes at record high after upbeat jobless claims report
May 6 REGN Regeneron Pharmaceuticals Inc (REGN) Q1 2021 Earnings Call Transcript
May 6 CCXI The Gross Law Firm Announces Class Actions on Behalf of Shareholders of RIDE, EBS and CCXI
May 6 CCXI INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of ChemoCentryx, Inc. (CCXI) on Behalf of Investors
May 6 CCXI CCXI DEADLINE ALERT: HAGENS BERMAN, National Trial Attorneys, Alerts ChemoCentryx (CCXI) Investors to Filing of Securities Class Action, Encourages Investors with Losses to Contact the Firm Now
May 6 CCXI DEADLINE FOR CCXI INVESTORS: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against ChemoCentryx, Inc.
May 6 REGN Regeneron Pharmaceuticals, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 6 REGN U.S. backing waiver of patent protection for vaccines is a ‘complex issue’: Doctor
May 6 CCXI SHAREHOLDER ALERT: XL VRM CCXI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
May 6 REGN Regeneron (REGN) Q1 Earnings Beat on Strong Eylea & Dupixent
May 6 CCXI CCXI INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against ChemoCentryx, Inc.

Dermatitis, also known as eczema, is a group of diseases that results in inflammation of the skin. These diseases are characterized by itchiness, red skin and a rash. In cases of short duration, there may be small blisters, while in long-term cases the skin may become thickened. The area of skin involved can vary from small to the entire body.Dermatitis is a group of skin conditions that includes atopic dermatitis, allergic contact dermatitis, irritant contact dermatitis and stasis dermatitis. The exact cause of dermatitis is often unclear. Cases may involve a combination of irritation, allergy and poor venous return. The type of dermatitis is generally determined by the person's history and the location of the rash. For example, irritant dermatitis often occurs on the hands of people who frequently get them wet. Allergic contact dermatitis occurs upon exposure to an allergen, causing a hypersensitivity reaction in the skin.Treatment of atopic dermatitis is typically with moisturizers and steroid creams. The steroid creams should generally be of mid- to high strength and used for less than two weeks at a time as side effects can occur. Antibiotics may be required if there are signs of skin infection. Contact dermatitis is typically treated by avoiding the allergen or irritant. Antihistamines may help with sleep and to decrease nighttime scratching.Dermatitis was estimated to affect 245 million people globally in 2015. Atopic dermatitis is the most common type and generally starts in childhood. In the United States, it affects about 10–30% of people. Contact dermatitis is twice as common in females than males. Allergic contact dermatitis affects about 7% of people at some point in time. Irritant contact dermatitis is common, especially among people who do certain jobs; exact rates are unclear.

More about Dermatitis
Browse All Tags